Relmada Therapeutics (RLMD) Equity Ratio (2012 - 2026)
Relmada Therapeutics (RLMD) reported Equity Ratio of 0.93 for Q1 2026, up 14.63% year-over-year from 0.81 in Q1 2025, and up 0.98% on a QoQ basis from 0.92 in Q4 2025.
Relmada Therapeutics (RLMD) has 15 years of Equity Ratio data on file, last reported at 0.93 in Q1 2026.
- Quarterly Equity Ratio rose 14.63% year-over-year to 0.93 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.93 (up 14.63% YoY) and the FY2025 annual result came in at 0.92, up 18.71% from the prior year.
- Equity Ratio climbed to 0.93 in Q1 2026 per RLMD's latest filing, from 0.92 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.93 in Q1 2022 and bottomed at 0.64 in Q3 2025.
- The 5-year median for Equity Ratio is 0.89 (2022), against an average of 0.86.
- Peak annual rise in Equity Ratio reached 18.71% in 2025, while the deepest fall reached 25.55% in 2025.
- Tracing RLMD's Equity Ratio over 5 years: stood at 0.92 in 2022, then fell by 4.73% to 0.87 in 2023, then dropped by 11.39% to 0.78 in 2024, then climbed by 18.71% to 0.92 in 2025, then climbed by 0.98% to 0.93 in 2026.
- Per Business Quant, the three latest RLMD Equity Ratio figures stand at 0.93 (Q1 2026), 0.92 (Q4 2025), and 0.64 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.21 |
| 10 | Relmada Therapeutics | 595.35 Mn | 595.35 Mn | - | 0.93 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.93 |
| Dec 31, 2025 | 0.92 |
| Sep 30, 2025 | 0.64 |
| Jun 30, 2025 | 0.76 |
| Mar 31, 2025 | 0.81 |
| Dec 31, 2024 | 0.78 |
| Sep 30, 2024 | 0.85 |
| Jun 30, 2024 | 0.87 |
| Mar 31, 2024 | 0.85 |
| Dec 31, 2023 | 0.87 |
| Sep 30, 2023 | 0.92 |
| Jun 30, 2023 | 0.91 |
| Mar 31, 2023 | 0.93 |
| Dec 31, 2022 | 0.92 |
| Sep 30, 2022 | 0.89 |
| Jun 30, 2022 | 0.91 |
| Mar 31, 2022 | 0.93 |
| Dec 31, 2021 | 0.93 |
| Sep 30, 2021 | 0.80 |
| Jun 30, 2021 | 0.87 |
| Mar 31, 2021 | 0.88 |
| Dec 31, 2020 | 0.89 |
| Sep 30, 2020 | 0.97 |
| Jun 30, 2020 | 0.98 |
| Mar 31, 2020 | 0.98 |
| Dec 31, 2019 | 0.99 |
| Sep 30, 2019 | 0.70 |
| Jun 30, 2019 | 0.74 |
| Mar 31, 2019 | 0.18 |
| Dec 31, 2018 | 0.43 |
| Sep 30, 2018 | -5.58 |
| Jun 30, 2018 | -1.81 |
| Mar 31, 2018 | -0.48 |
| Dec 31, 2017 | 0.11 |
| Sep 30, 2017 | 0.26 |
| Jun 30, 2017 | 0.51 |
| Mar 31, 2017 | 0.67 |
| Dec 31, 2016 | 0.75 |
| Sep 30, 2016 | 0.70 |
| Jun 30, 2016 | 0.69 |
| Mar 31, 2016 | 0.80 |
| Dec 31, 2015 | 0.71 |
| Sep 30, 2015 | 0.68 |
| Jun 30, 2015 | 0.36 |
| Mar 31, 2015 | 0.09 |
| Dec 31, 2014 | 0.14 |
| Sep 30, 2014 | -0.74 |
| Jun 30, 2014 | -0.04 |
| Nov 30, 2013 | -2.28 |
| Aug 31, 2013 | -0.68 |
| May 31, 2013 | -4.50 |
| Feb 28, 2013 | -0.18 |
| Aug 31, 2012 | 0.62 |